Abivax Completes Recruitment of ABX464 Phase IIa HIV Study
Go back to Abivax Completes Recruitment of ABX464 Phase IIa HIV Study| (NASDAQ: ABVX) | Delayed: 88.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.01 | 52 Week High | $ | |||
| Open | $88.01 | 52 Week Low | $ | |||
| Day High | $88.01 | P/E | N/A | |||
| Day Low | $88.01 | EPS | $ | |||
| Volume | 3,293 | |||||



